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ABSTRACT
Objective: To analyze the histological behavior of bovine lyophi-
lized grafts (BLG) produced according to a protocol developed 
by the first author, in humans over a 49-month period by mea-
suring the graft/bone neoformation ratio in relation to the total 
mineralized area. Methods: This was a case series involving 12 
patients: eight females (66%) and four males (34%), totaling 13 
biopsies. BLG was used, and surgical reintervention was subse-
quently required during the period 2000 to 2011. The slides pro-
duced were stained with hematoxylin-eosin (HE), were analyzed 
by a pathologist and were digitized for the proposed evaluation. 
Results: The mean age was 57 years and the mean follow-up was 
49 months (range: 6-115). The average proportion of BLG was 
42% (range: 13-85) and neoformed bone, 58% (range: 15-87) 
in relation to the total area mineralized. Conclusions: This stu-
dy demonstrated that the BLG used presented osteoconductive 
characteristics and biocompatibility. BLG is a therapeutic option 
that can be used in orthopedic surgery in which bone defects 
need to be filled.
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INTRODUCTION
The use of bone transplants in orthopedic surgery 
and dentistry has become indispensable in many 
procedures, including revisions of total hip (RTHA) 
and knee arthroplasty (RTKA)(1-3). Despite its great 
power of repair, bone tissue does not always respond 
appropriately when affected by extensive osteolysis(4). 
In these cases, which are highly prevalent in orthopedics, 
high quality bone substitutes or other biomaterials that 
can fill and restore these gaps need to be sought(4). A 
key factor related to the quality of a graft as a bone 
substitute is the process of bone formation triggered 
in the host(5). The biological events responsible for 
osseointegration are osteogenesis, osteoinduction, and 
osteoconduction(4). A biopsy is the gold standard method 
to determine the phenomena occurring in the graft, and 
radiographic studies provide only a macroscopic view 
of what happens microscopically.
Different types of bone grafts are currently available 
for orthopedic reconstruction: autologous, homologous 
and heterologous – xenogenic –, and may be sterilized 
and preserved by freezing or lyophilization, among 
other means(5-9). From the point of view of integration, 
the autograft is considered the ideal and preferred 
replacement; however, limitations as the quantity 
available and the risk of complications – local and 
systemic, ranging from 21% to 49% – are inherent in 
the intervention needed for its withdrawal, restricting 
its applicability(1,10,11). The frozen allogenic graft is 
widely used in RTHA, but is not always available, 
and despite strict controls, poses risk of transmission 
of infectious diseases and tumors(6,12-14). Heterologous 
grafts, specifically lyophilized bovine graft (LBG), are 
© 201  Sociedade Brasileira de Ortopedia e Traumatologia. Open access under CC BY-NC-ND license.2
771
Rev Bras Ortop. 2012;47(6):770-5
BOVINE LYOPHILIZED GRAFT (BLG): HISTOLOGICAL ANALYSIS ON BEHAVIOR IN HUMANS AFTER 49 MONTHS
an option that has been used in several medical areas, 
due to being easily obtainable, highly available and 
being highly similar to the human bone(6). To decrease 
the antigenicity and preserving only the protein-
mineral matrix, the LBG is washed, degreased, and 
decellularized, and is then dehydrated. The bovine 
bone – raw material for obtaining the proposed graft 
– has a chemical composition, porosity, size, shape, 
and biological behavior similar to that of human bone, 
providing the support structure and osteoconduction, 
besides providing high content of calcium and 
phosphorus, which are essential for the neoformation 
of bone tissue(4). Several studies show this type of 
grafting experiment in animals(15-19); however, only 
one performed histological analysis in humans(20). 
The results of animal studies are hardly applicable in 
humans because of existing physical and biological 
differences between them. Thus, studies that will 
elucidate the behavior of xenografts in humans are of 
great value.
The fundamental hypothesis of the study, 
related to the use of the LBG produced according 
to the protocol developed by the main author, is its 
applicability as a temporary structural support that 
allows osteoconduction and integration of the newly 
formed bone in deficient areas, promoting satisfactory 
filling. Our study is justified since there is little 
detailed information on the subject and the available 
data are controversial(17-22).
This study aims to analyze the histological behavior 
of this LBG specifically, in humans, during 49 (six to 
115) months by measuring the ratio between the graft 
and bone formation in relation to total mineralized area.
MATERIALS AND METHODS
The study design is a series of cases that analyzed 
the histological findings of the LBG produced according 
to the protocol developed by the main author(11-12), in 
partnership with Baumer (Mogi Mirim, São Paulo, Brazil) 
and the Hospital de Clínicas Porto Alegre (HCPA), in 
human models. The protocol used for this production 
was based on a modification of that of Kakiuchi et al(23) 
of Osaka University, Japan, published in 1996. After 
the modifications, the LBG maintained the chemical 
(protein-mineral composition) and structural nature of 
the raw material virtually unchanged, fostering a product 
that was suitable for its intended use, therefore, with 
applicability in humans(13).
The group studied consists of 12 patients, totaling 
13 samples, collected from July 2000 to January 2011 
(mean of 49 months). The LBG was used alone as a 
graft in cases with significant bone defects – subjec-
tively evaluated by the orthopedic team – resulting 
from an acute or chronic pre-existing pathology. The 
inclusion criterion was the need to use LBG in pri-
mary surgeries or reoperations that the patients may 
have undergone. Most of these were in good clinical 
condition and had no pathology that contraindicated 
surgery; however, it is worth clarifying: in the patient 
JARS, due to the large volume of LBG used in the 
first surgery, it was possible to collect two biopsies 
from different areas to be counted as two cases; pa-
tient SG showed signs of infection in the first surgery, 
and the RTHA was performed in the same procedure 
as grafting.
The biopsies were collected at the time of reinter-
vention (due to causes unrelated to grafting).
It is important to emphasize that in no way was any 
procedure performed with the sole purpose of removing 
bone fragments for analysis of the behavior of the 
graft. The follow-up period was estimated from the 
primary intervention until the time of biopsy. Seven of 
these were collected using a Yamshidi needle, guided 
by the image intensifier, with cylindrical shape and 
measuring approximately 6 mm long and 2 mm in 
diameter, the remaining six, under direct vision with the 
aid of a biopsy punch or curette. All were immediately 
immersed in the appropriate fixative during surgery 
and sent for further analysis according to protocol. 
In the pathology laboratory, the samples were fixed 
for 12 to 16 hours in 10% buffered formalin, with 10 
times the volume of the sample. Sequentially, they were 
washed to remove excess fixative and transferred to 
a softener, which promoted the removal of calcium 
phosphate from the bone tissue, using 10% nitric acid 
(155 ml of 65% nitric acid and 845 ml distilled water) 
for approximately 24 hours. Afterwards, they were 
washed with distilled water for six hours to remove 
the acid and embedded in paraffin, melted at 60°C, 
to form blocks. Slides were then prepared from serial 
transverse sections, that were 200-μm on average, with 
a steel blade, and stained with hematoxylin-eosin (HE). 
During this process, the HE showed the LBG to be 
slightly bluish, not matching the areas of osteogenesis 
that are pink under microscopy (Figures 1 and 2). So, 
after scanning the images, the areas occupied by each 
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Figure 1 – Lyophilized bovine graft (LBG) stained blue with hematoxylin-eosin 
(HE). 10x magnification. HCPA 2011.
Figure 2 – Blue areas denote the lyophilized bovine graft (LBG) stained 
with hematoxylin-eosin (HE). 100x magnification. HCPA 2011.
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compound can clearly be seen and measured. A doctor 
from the Pathology Clinic – blinded to those cases – 
was responsible for the histological analysis of the 
slides, discerning – according to the doctor’s own 
criteria – the following findings: resorption of the graft, 
presence of signs of inflammation and/or infection 
(neutrophils), neoformation bone, and fibrosis. After 
this, a second group of researchers, independent and 
similarly blinded with respect to cases, digitized the 
slides and measured the mineralized areas occupied 
by the LBG and the newly formed bone. Micrographs 
were taken through a microscope (Axiolab E, Carl 
Zeiss, Gottingen, Germany) coupled with a high-
definition camera (Sony Inc., Japan). The images 
were inserted into a graphics program (ImageJ 1.40 
– National Institutes of Health, USA, http://rsb.info.
nih.gov/ij/) for accurate quantification of each area. 
Histomorphometric parameters were described as 
pixels by a semi-automatic analysis system; these 
data were transferred to Excel for Windows, which 
defined the proportions of each component within the 
total mineralized area.
Statistical analysis was performed using SPSS 13 
for Windows (SPSS Inc. Chicago, IL, USA). Descrip-
tive analyses are presented as mean, maximum, and 
minimum values for quantitative variables and per-
centage for qualitative variables.
All of the risks, benefits, and the purpose of the sur-
gery and bone biopsies were made clear to the patients 
prior to the study, and each was required to sign an 
informed consent form agreeing with every phase. This 
study was conducted by the Hip Group of the Orthope-
dics and Traumatology Clinic, Department of Surgery, 
Hospital de Clínicas de Porto Alegre (HCPA), Univer-
sidade Federal do Rio Grande do Sul (UFRGS), in col-
laboration with the Pathology Clinic of the institution. 
This study was approved by the research and ethics 
committee of the graduate group (GPPG) of HCPA.
RESULTS
Global analysis
All demographic data are shown in Table 1. The 
average age in the group was 51 years (24 to 82), 
consisting of four (34%) male and eight (66%) fe-
male patients. The average length of hospitaliza-
tion was 10 (3-38) days and mean follow-up was 49 
months (6-115).
Histological analysis
The slides showed a homogeneous histological 
pattern when examined microscopically by the 
pathologist according to their own criteria (Table 2). 
None of them showed an exacerbated inflammatory 
response in the periphery of the LBG, which rules 
out the chance of the body rejecting the foreign 
body. Neutrophils were only detected in the lamina 
of patient SG. The presence of varying amounts of 
fibrosis (Figure 3), signs of a partially resorbed graft 
(Figure 4), and osteogenesis (Figure 5) were evident 
in all samples. Avital bone tissue, corresponding to the 
LBG, which was stained in blue, and vitalized tissue 
(with nucleated cells) representing newly formed bone, 
were present in the slides analyzed. The integration 
between the original bone, the LBG, and the areas of 
new bone formation are microscopically well defined 
and occur in large blocks, but maintaining a clear 
boundary between each (Figure 6).
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Figure 3 – Fibrosis represented by whitish light areas in the center of the 
image. 200x magnification. HCPA 2011.
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Table 1 – Demographic data. 
Patient Sex Age (years) Procedure Diagnosis Hospitalization (days) Evolution (months)
1 1 24 FO Femoral pseudarthrosis 9 6
2 1 25 TCA Talocalcaneal arthrosis 3 59
3 2 82 RTHA Material wear and tear 10 9
4 2 51 RTHA Material wear and tear 9 72
5 2 64 RTHA Material wear and tear 10 43
6 2 30 FO Simple bone cyst 14 68
7 2 79 RTHA Material wear and tear 38 19
8 2 55 THA Coxarthrosis 7 82
9 2 60 RTHA Material wear and tear 12 50
10 1 45 TO Material wear and tear 3 35
11 1 43 FO Femoral pseudarthrosis 11 16
12 1 48 RTHA Material wear and tear 7 115
1: Male, 2: Female; TO: Tibial osteosynthesis, FO: Femoral osteosynthesis, EBC: Excision of bone callus, TCA: Talocalcaneal arthrodesis, THA: Total hip arthroplasty, RTHA: revision of THA. HCPA 2011
Table 2 – Histological analysis of slides.




ALL - + + +
JARS 1 - + + +
JARS 2 - + + +
MTRC - + - +
EG - + + +
AMB - + + +
TGG - + + +
AACS - + + +
MB - + + +
SG + + + -
MH - + + +
HJCS - + + +
MAR - + + +
+: present, -: absent. HCPA 2011
Figure 4 – Lyophilized bovine graft (LBG) (blue areas) surrounded by newly 
formed bone tissue (pink areas). 200x magnification. HCPA 2011.
Figure 5 – Partially resorbed (blue areas) of lyophilized bovine graft (LBG) 
surrounded by newly formed bone tissue (pink areas). 200x magnification. 
HCPA 2011.
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Figure 6 – Well-defined boundaries between the bluish lyophilized bovine 
graft (LBG) and the pink new bone. 400x magnification. HCPA 2011.
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specific analysis
The digitized slides showed a mean proportion of 
42% (13-85%) of lyophilized bovine graft and 58% 
(15-87%) of new bone formation in relation to the 
total mineralized area (Table 3). Importantly, two pa-
tients showed significant differences in relation to the 
other samples with a ratio of LBG/bone formation of 
85/15% and 76/24%, and the slides were reviewed, in 
order to exclude any measurement errors.
Table 3 – Proportions measured.
 LBG Neoformation Follow-up*
ALL 37% 63% 6
JARS 1 34% 66% 59
JARS 2 34% 66% 59
MTRC 23% 77% 9
EG 32% 68% 72
AMB 60% 40% 43
TGG 85% 15% 68
AACA 26% 74% 19
MB 13% 87% 82
SG 76% 24% 50
MH 47% 53% 62
HJCS 38% 62% 16
MAR 39% 61% 115
* months
radiographic analysis
The radiographs of all patients showed satisfactory 
consolidation in the perimeter of the graft.
DISCUSSION
The possibility of using lyophilized bovine graft 
(LBG) as an alternative to autologous graft in orthope-
dic surgery has been investigated for some time, par-
ticularly in animal models(6). This study contributes 
information that is extremely relevant to the use of 
LBG, produced according to the protocol developed 
by the main author, in humans, since it demonstrates 
its osseointegration. Previous studies endorse the use 
of this LBG both in animals(15,16) and in humans(2,5,18). 
Meyer et al(21) brought forth the first data relating 
to histological osseointegration in relation to LBG –
Tutobone® – in humans. These results were promis-
ing, prompting us to evaluate our biopsies and com-
pare the results with those available in the literature.
In our study, which has a design similar to Meyer 
et al(21), we found a proportion of 42% preservation 
of the LBG and 58% related to areas of new bone 
formation compared to the total mineralized area on 
the slides analyzed in an average period of 49 months. 
These data are very similar to those presented by this 
author, who reports having 47% preservation with 
Tutobone® and 53% of new bone formation in the 
course of 11 months in nine samples.
The presence of LBG in the biopsies allows us 
to infer that the graft proposed presents undeniable 
osteoconductivity, being only partially reabsorbed 
in humans, unlike the complete remodeling which 
occurs in animals. We found no linear correlation 
between the duration of follow-up and proportions 
of LBG/bone formation in relation to the total 
mineralized area, and it was not possible to define 
an exact pattern of behavior, as the sample with nine 
months of follow-up had a higher rate of neoformed 
bone than at 62 months. The fact that the slide that 
had the highest rate of new bone formation (87%) 
was one of the longest durations of follow-up (82 
months) is also relevant. Thus, we can say that the 
LBG used promotes satisfactory, efficient, and durable 
osseointegration, with human bone tissue during the 
follow-up period measured.
It is interesting to note that in two samples there 
were important differences in relation to the others, 
which were confirmed after further analysis: the LBG/
osteogenesis ratio of 85/15% and 76/24%, showing 
less osteoblastic activity around the graft. There was 
less bone remodeling in these cases, suggesting some 
biological or mechanical limiting factor in bone re-
pair. One has Albright syndrome with severe bone and 
metabolic impairment, which may be a factor related 
to reduced bone formation. Importantly, even these 
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samples showed no difference in the rate of consoli-
dation, or worse clinical outcomes.
This leads us to think that the type and quantity 
of graft applied are not solely responsible for the ca-
pacity for new local bone formation, but that every 
organism, with its different biological characteristics, 
affects the response of the osseointegration process. 
Elucidating this is not the purpose of the present 
study, but it could justify the behavior. The absence 
of a foreign body reaction in all slides demonstrates 
the biocompatibility of the lyophilized bovine graft 
developed by our group in this study.
The presence of satisfactory osseointegration in 
radiographic examinations shows that the LBG in 
this study presents a visual pattern similar to other 
commonly used types of grafts. Previous experi-
ments showed full osseointegration in 75.8% after 
six months and nearly all cases at 12 months(21).
We did not use a control group, since the study 
design did not allow for it. The objective of the study 
is to evaluate the histological behavior of LBG in 
humans and not to discuss its superiority. 
CONCLUSION
This is the first histological study using lyophilized 
bovine graft (LBG), produced according to the pro-
tocol developed by the main author, in humans. The 
results show that this graft had satisfactory biocom-
patibility and did not harm the patients. Additionally, 
it showed good osteoconduction and integration in an 
average follow-up period of 49 months, fulfilling the 
role that was expected of it.
The results obtained are promising and contribute 
to strengthening the role of the LBG as a treatment 
option for dental and orthopedic surgeries that require 
some type of graft to fill bone defects.
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